SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-014326
Filing Date
2017-07-28
Accepted
2017-07-27 18:53:19
Documents
5
Period of Report
2017-07-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K UNDERWRITING AGREEMENT reta-8k_20170727.htm 8-K 40577
2 EX-1.1 UNDERWRITING AGREEMENT reta-ex11_49.htm EX-1.1 236191
3 EX-5.1 V&E OPINION reta-ex51_120.htm EX-5.1 15781
4 GRAPHIC g201707272158152615194.jpg GRAPHIC 9584
5 GRAPHIC g201707272158152205194.jpg GRAPHIC 27284
  Complete submission text file 0001564590-17-014326.txt   344739
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 17987448
SIC: 2834 Pharmaceutical Preparations